Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial.
Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. Maitre P, et al. Among authors: pal m. Int J Radiat Oncol Biol Phys. 2024 Mar 28:S0360-3016(24)00439-5. doi: 10.1016/j.ijrobp.2024.03.023. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38552989
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial.
Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U. Murthy V, et al. Among authors: pal m. J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26. J Clin Oncol. 2021. PMID: 33497252 Clinical Trial.
Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL).
Murthy V, Mallick I, Gavarraju A, Sinha S, Krishnatry R, Telkhade T, Moses A, Kannan S, Prakash G, Pal M, Menon S, Popat P, Rangarajan V, Agarwal A, Kulkarni S, Bakshi G. Murthy V, et al. Among authors: pal m. BMJ Open. 2020 Feb 28;10(2):e034623. doi: 10.1136/bmjopen-2019-034623. BMJ Open. 2020. PMID: 32114475 Free PMC article. Clinical Trial.
Optimizing Target Volume for Adjuvant Radiation Therapy in Penile Cancer.
Khurud P, Gupta A, Krishnatry R, Panigrahi G, Phurailatpam RD, Menon S, Pal M, Bakshi G, Prakash G, Murthy V. Khurud P, et al. Among authors: pal m. Pract Radiat Oncol. 2023 May-Jun;13(3):e270-e277. doi: 10.1016/j.prro.2022.11.001. Epub 2022 Nov 30. Pract Radiat Oncol. 2023. PMID: 36460183
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer.
Murthy V, Maitre P, Singh M, Pal M, Arora A, Pujari L, Kapoor A, Pandey H, Sharma R, Gudipudi D, Joshi A, Prabhash K, Noronha V, Menon S, Mehta P, Bakshi G, Prakash G. Murthy V, et al. Among authors: pal m. Clin Oncol (R Coll Radiol). 2023 Sep;35(9):e506-e515. doi: 10.1016/j.clon.2023.04.010. Epub 2023 May 5. Clin Oncol (R Coll Radiol). 2023. PMID: 37208232
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
Prakash G, Pal M, Odaiyappan K, Shinde R, Mishra J, Jalde D, Rajkumar B, Prabhash K, Joshi A, Noronha V, Murthy V, Krishnatry R, Desai S, Menon S, Sable N, Popat P, Rangarajan V, Agrawal A, Bakshi G. Prakash G, et al. Among authors: pal m. Indian J Cancer. 2019 Jan-Mar;56(1):54-58. doi: 10.4103/ijc.IJC_351_18. Indian J Cancer. 2019. PMID: 30950446 Free article.
1,081 results